Present situation of multidrug resistent tuberculosis in Asian countries and the possibility of MDR-TB treatment by new quinolones

Más información sobre el libro

This publication presents the latest data on the incidence of multi-drug resistant tuberculosis (MDR-TB) infections in Taiwan, China, Thailand, Indonesia and the US. The health care systems of these countries, both at the local and national level, are characterized, and the strategies of how they are dealing with this increasing problem are described. The need to supervise patients when they receive treatment is stressed. Results from clinical trials using ofloxacin as part of the anti-TB medication for treating MDR-TB are reported from each country. An overview of the global situation as well as a historical review and reasons for the development of MDR-TB together with clear-cut guidelines for prevention are also provided. The information compiled in this issue will be of great practical value to anyone involved in TB control and treatment, such as respiratory and infectious disease specialists, public health experts and government health organizations.